Description
Wormeeclear (Mebendazole) 500 mg
Wormeeclear 500 mg tablets are a mebendazole medicine used for intestinal worm infections. Mebendazole is an established anthelmintic, meaning it acts against parasitic worms. The exact licensed uses can vary by country and product label.
Active Ingredient and Medicine Class
The verified active ingredient is mebendazole. It belongs to the benzimidazole anthelmintic class. This group is used against several intestinal nematodes, and mebendazole has long been included among standard antiparasitic medicines in official and review literature.
Established Medical Uses
Mebendazole is used for common intestinal helminth infections, especially infections caused by roundworm, whipworm and hookworm. Regulatory and review sources also describe its role in treatment of soil-transmitted nematode infections. Specific approved indications depend on the local product licence.
How It Works
Mebendazole disrupts worm metabolism by blocking glucose uptake and impairing energy production in susceptible parasites. This weakens and kills the worms, helping clear intestinal infection.
Important Safety Information
Mebendazole should not be used in people with known hypersensitivity to mebendazole or related benzimidazole medicines. U.S. prescribing information also warns against use with metronidazole because serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported. Regulatory sources note that mebendazole is not recommended in early pregnancy, particularly the first trimester. Product labels also describe caution in very young infants and other patients where safety data are limited.
Possible Side Effects
Reported side effects include abdominal discomfort, diarrhoea, flatulence, nausea and vomiting. Less common but important reactions include allergic skin reactions and, rarely, serious cutaneous adverse reactions. Post-marketing reports also include liver-related abnormalities and blood-count changes in some mebendazole products.
Scientific Evidence
PubMed-indexed reviews and clinical literature support mebendazole as an established treatment for intestinal nematode infections. A review of single-dose 500 mg mebendazole found evidence for activity against soil-transmitted helminths, including Ascaris lumbricoides and Trichuris trichiura. Broader review literature also describes mebendazole as one of the main anthelmintics used for common intestinal worm infections.
Medical Information Notice
This educational summary is based on sources available at the time of review and does not replace the official patient leaflet, prescribing information or individual assessment by a qualified healthcare professional.
Medical Sources
- U.S. FDA / DailyMed: EMVERM (mebendazole) chewable tablets, prescribing information. View source
- J Mrus et al.: “Efficacy of single-dose 500 mg mebendazole in soil-transmitted helminth infections: a review.” Journal of Helminthology, 2018. View PubMed article
